Global Biopharmaceutical Company
Establishing a Transport Validation Strategy for a Commercial-Ready Biologic Product
Challenge
A global biopharmaceutical company developing a temperature-sensitive biologic combination product needed to validate its end-to-end supply chain in preparation for commercial distribution. The therapy, delivered in a prefilled syringe configuration, required assurance that product quality and device functionality could be maintained across a wide range of real-world and worst-case shipping conditions.
To support regulatory review and global launch readiness, the company sought a partner with deep expertise in cold chain engineering, transport validation, and risk-based qualification strategies for complex biologic products.
Objectives
-
Map supply chain conditions and define transport requirements.
-
Conduct a risk assessment to identify and mitigate potential transport hazards.
-
Develop a Validation Master Plan detailing strategy, scope, and approach.
-
Execute risk-based transport qualification and simulated distribution studies.
-
Select and qualify active and passive thermal packaging solutions.
-
Oversee performance qualification (PQ) studies and compile validation reports.
-
Support global and FDA submissions with regulatory-ready documentation.
Results
Modality Solutions delivered a comprehensive, risk-based cold chain validation strategy that demonstrated the robustness of the prefilled syringe system across diverse distribution conditions. The data generated through transport qualification, simulated distribution testing, and packaging assessments supported regulatory review and contributed to the product’s successful progression toward approval and commercial readiness.
Explore the full case study to see how a structured validation framework helped enable global distribution confidence for a complex biologic combination product.
Download the full case study